-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P+d2+FhbS3fjzAeAsTrUkco0jk9wQXtiYQfIZD0RWIQ1AoZrZBB9rAMTpwkfXl+i 5z7libjT05gLdaokIFvv6Q== 0001127602-09-011027.txt : 20090508 0001127602-09-011027.hdr.sgml : 20090508 20090508171614 ACCESSION NUMBER: 0001127602-09-011027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090507 FILED AS OF DATE: 20090508 DATE AS OF CHANGE: 20090508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERLMUTTER ROGER M CENTRAL INDEX KEY: 0001184228 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 09811811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 BUSINESS PHONE: 805-447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE STREET 2: MAIL STOP 27-3-C CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2009-05-07 0000318154 AMGEN INC AMGN 0001184228 PERLMUTTER ROGER M ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 Exe VP, Research & Development Common Stock 2009-05-07 4 A 0 19207 0 A 157980 D Common Stock 2009-05-08 4 F 0 8788 47.63 D 149192 D These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. /s/ N Cris Prince, Attorney-in-Fact for Dr. Perlmutter 2009-05-08 -----END PRIVACY-ENHANCED MESSAGE-----